Apollo Ventures

Restore homeostasis in metabolic activity and stress response Regenerate tissues by altering the cellular and extracellular environment Validate the viability of a project and create the foundation for new biotech ventures Establish collaborations with experts and key opinion leaders Identify, secure and protect IP and know-how Design “killer experiment” to derisk project Define research and development plan and budget Execute strategy for time and cost efficient development of novel therapeutics Leadership team with deep expertise in biotech, scientific and medical talent and advisors Lean and flexible drug development to maximize capital efficiency of start-ups Clinical development for existing indications of high unmet medical need with clear regulatory paths Learn more about recent advances in longevity, biotechnology and our work

Cleara Biotech Raises $2.5 Million in Seed Financing led by Apollo Health Ventures and appoints Dr. Angelos Stergiou as Board of Directors Chairman

Auron Therapeutics Announces $48 Million Series A Financing to drive novel oncology pipeline leveraging a machine learning, multi-omics based platform

Haya Therapeutics, backed by Apollo since March 2021, listed among Europe's top biotech investments

We are looking forward to hearing from you about opportunities to collaborate and share more information about our work